)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
Caribou Biosciences
Caribou Biosciences (CRBU) investor relations material
Caribou Biosciences Citi’s 2026 Virtual Oncology Leadership Summit summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Citi’s 2026 Virtual Oncology Leadership Summit summary19 Feb, 2026
Conference overview
Virtual Oncology Summit 2026 featured fireside chats and one-on-ones with biotech leaders, focusing on next-generation therapies for cancer treatment.
Key sessions included discussions on allogeneic CAR-T cell therapies and their transformative potential for broader patient access.
Insights from both academic and community hospital physicians highlighted the need for off-the-shelf cell therapies.
The summit emphasized the logistical and clinical barriers limiting current autologous CAR-T access.
The event provided updates on pivotal clinical programs and future trial designs.
Technology and clinical program updates
chRDNA CRISPR platform enables highly specific genome editing, advancing allogeneic CAR-T therapies.
Vispa-cel, for large B cell lymphoma, showed phase I results on par with autologous CAR-Ts and is now pivotal-ready.
CB-011, targeting multiple myeloma, demonstrated response rates exceeding bispecific antibodies in early trials.
Both programs leverage learnings on donor age and HLA matching to optimize outcomes.
Ongoing dose expansion and longer-term follow-up data are expected this year.
Market need and access
Only 25% of large B cell lymphoma and 10% of myeloma patients currently access auto CAR-Ts due to speed and geography.
Allogeneic CAR-Ts could address the majority of patients who cannot access current therapies.
Community hospitals are eager to participate in pivotal studies and future commercial launches.
Off-the-shelf therapies could transform care by enabling broader, faster access.
Commercial opportunity is significant, with physician discretion expected to drive adoption.
Vispa-cel: Dual-ineligible patient strategy impact?
CB-011: What pivotal strategy maximizes market share?
Allo CAR-T: Community site readiness for LD regimen?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Caribou Biosciences earnings date
Leerink Global Healthcare Conference 202610 Mar, 2026
Caribou Biosciences
Next Caribou Biosciences earnings date
Leerink Global Healthcare Conference 202610 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Caribou Biosciences Inc. is a clinical-stage biopharmaceutical company at the forefront of genome editing technology. It focuses on developing genome-edited allogeneic cell therapies for the treatment of cancer and other devastating diseases. The company utilizes CRISPR-Cas9 technology to create precise, directed changes in the DNA of living cells, aiming to develop innovative therapies that can address unmet medical needs. Caribou's leading product candidates include allogeneic chimeric antigen receptor T (CAR-T) cell therapies for hematologic malignancies and solid tumors. This approach allows for the development of therapies that are not patient-specific but can be used as "off-the-shelf" treatments, potentially reducing time and cost compared to traditional autologous CAR-T therapies. The company is headquartered in Berkeley, CA, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage